Back to search

Article

Enhancing evidence-based guidelines using trial emulation in electronic health records: Real-world effects of empagliflozin in people with type 2 diabetes

2025-09-18

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> There is growing interest in widening the use of sodium-glucose co-transporter-2 inhibitors (SGLT2i) to all people with type 2 diabetes mellitus (T2DM). However, pivotal randomised controlled trials (RCTs) evaluated these drugs only in highly selected populations, often lacking generalisability to real-world populations. Understanding the effects of SGLT2i in populations, wh...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
27f1eefe-e33d-58f6-ae59-cb8cfa76eef9
DOI
10.1101/2025.09.17.25335885
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enhancing evidence-based guidelines using trial emulation in electronic health records: Real-world effects of empagliflozin in people with type 2 diabetesDOI 10.1101/2025.09.17.25335885
Select a neighboring publication to make it the new centre.